×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [21]
厦门大学 [8]
复旦大学上海医学院 [6]
上海生物化学与细胞生... [5]
大连化学物理研究所 [3]
中国科学院大学 [3]
更多...
内容类型
期刊论文 [60]
发表日期
2018 [5]
2017 [3]
2016 [3]
2015 [5]
2014 [4]
2013 [7]
更多...
学科主题
Biochemist... [2]
Biochemist... [1]
Biochemist... [1]
Biotechnol... [1]
Oncology [1]
Science & ... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共60条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells
期刊论文
ANTI-CANCER DRUGS, 2018, 卷号: 29, 期号: 10, 页码: 965-974
作者:
Guo, Chuanlong
;
Wang, Lijun
;
Jiang, Bo
;
Shi, Dayong
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2019/05/15
antiangiogenesis
curcumin analogs
hypoxia-inducible factor-1 alpha
human umbilical vein endothelial cells
vascular endothelial growth factor
Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells
期刊论文
ANTI-CANCER DRUGS, 2018, 卷号: 29, 期号: 10, 页码: 965-974
作者:
Guo, Chuanlong
;
Wang, Lijun
;
Jiang, Bo
;
Shi, Dayong
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2018/12/21
antiangiogenesis
curcumin analogs
hypoxia-inducible factor-1 alpha
human umbilical vein endothelial cells
vascular endothelial growth factor
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis
期刊论文
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:
Fang, Xiaona
;
Xie, Hua
;
Luo, Min
;
Chen, Zhen
;
Wang, Fang
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/01/08
Angiogenesis
And-tumor activity
Multi-tyrosine kinases inhibitor
PBA2
VEGFR2
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models
期刊论文
MOLECULAR CANCER THERAPEUTICS, 2018, 卷号: 17, 期号: 4, 页码: 751-762
作者:
Ai, Jing
;
Chen, Yi
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2019/01/08
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor
期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2019/01/08
angiogenesis
anlotinib
tyrosine kinase inhibitor
VEGF
VEGFR2
Co-delivery of itraconazole and docetaxel by core/shell lipid nanocells for systemic antiangiogenesis and tumor growth inhibition
期刊论文
Journal of biomedical nanotechnology, 2017, 卷号: 13, 期号: 11, 页码: 1398-1412
作者:
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2019/04/23
Antiangiogenesis
Itraconazole
Docetaxel
Core/shell nanocarrier
Combinational therapy
3D numerical simulation of effect of antiangiogenic factor angiostatin on blood flow and interstitial fluid pressure in the metastatic tumor
期刊论文
MCB Molecular and Cellular Biomechanics, 2017, 卷号: 14, 期号: 1
作者:
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/12/05
Anti-angiogenesis through noninvasive to minimally invasive intraocular delivery of the peptide CC12 identified by in vivo-directed evolution
期刊论文
BIOMATERIALS, 2017, 卷号: 112, 页码: 218-233
作者:
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/01/08
Angiogenesis inhibitor
Cell-penetrating peptides
Intraocular drug delivery
In vivo-direction evolution
Neovascularization
Phage display
Discovery of 3-(5 '-substituted)-benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazoles as potent fibroblast growth factor receptor inhibitors: design, synthesis, and biological evaluation
期刊论文
Journal of medicinal chemistry, 2016, 卷号: 59, 期号: 14, 页码: 6690-6708
作者:
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/05/09
Discovery of 3-(5 '-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 14, 页码: 6690-6708
作者:
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/01/08
©版权所有 ©2017 CSpace - Powered by
CSpace